Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response

Infection and Immunity

Volumn 71, Issue 3, 2003, Pages 1185-1193

  Gomes, J A S ^a,b   Bahia Oliveira, L M G ^c   Rocha, M O C ^a   Martins Filho, O A ^b   Gazzinelli, G ^b   Correa Oliveira, R ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c UNIVERSIDADE ESTADUAL DO NORTE FLUMINENSE DARCY RIBEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CELL CULTURE; CELLULAR IMMUNITY; CHAGAS DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; MACROPHAGE; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; MORBIDITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TH1 CELL; TRYPANOSOMA CRUZI;

ADULT; AGED; CHAGAS CARDIOMYOPATHY; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; MIDDLE AGED; TH1 CELLS;

EID: 0037372978     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.3.1185-1193.2003     Document Type: Article

References (36)

1. Abel, L. C., L. V. Rizzo, B. Ianni, F. Albuquerque, F. Bacal, D. Carrara, E. A. Bocchi, H. C. Teixeira, C. Mady, J. Kalil, and E. Cunha-Neto. 2001. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J. Autoimmun. 17:99-107.
2. Bahia-Oliveira, L. M. G., J. A. S. Gomes, M. O. C. Rocha, M. C. Moreira, E. M. Lemos, Z. M. Luz, M. E. Pereira, R. L. Coffman, J. C. Dias, J. R. Cancado, G. Gazzinelli, and R. Correa-Oliveira. 1998. IFN-γ in human Chagas' disease: protection or pathology? Braz. J. Med. Biol. Res. 31:127-131.
3. Bahia-Oliveira, L. M. G., J. A. S. Gomes, J. R. Cançado, T. C. Ferrari, E. M. Lemos, Z. M. Luz, M. C. Moreira, G. Gazzinelli, and R. Correa-Oliveira. 2000. Immunological and clinical evaluation of chagasic patients subjected to chemotherapy during the acute phase of Trypanosoma cruzi infection 14-30 years ago. J. Infect. Dis. 182:634-638.
4. Brener, Z., and R. T. Gazzinelli. 1997. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas disease. Int. Arch. Allergy Immunol. 114:103-110. arsid473053
5. Dias, J. C. P. 1989. The indeterminate form of human chronic Chagas' disease a clinical epidemiological review. Rev. Soc. Bras. Med. Trop. 22:147-156.
6. Dutra, W. O., K. J. Gollob, J. C. Pinto-Dias, G. Gazzinelli, R. Correa-Oliveira, R. L. Coffman, and J. F. Carvalho-Parra. 1997. Cytokine mRNA profile of peripheral blood mononuclear cells isolated from individuals with Trypanosoma cruzi chronic infection. Scand. J. Immunol. 44:74-80.
7. Gazzinelli, G., N. Katz, R. S. Rocha, and D. G. Colley. 1983. Immune responses during human schistomiasis mansoni. VIII. Differential in vitro cellular responsiveness to adult worm and schistosomular tegumental preparations. Am. J. Trop. Med. Hyg. 32:326-333.
8. Gazzinelli, R. T., M. Wysocka, T. Scharton-Kertein, A. Cheever, R. Kuhn, W. Muller, G. Trinchieri, and A. Sher. 1996. In the absence of endogenous IL-10 mice acutely infected with Toxoplasma gondii sucumb to a lethal immune response dependent on CD4+ T cells and accompanied by overexpression of IL-12, IFN-γ and TNF-α. J. Immunol. 157:798-805.
9. Gazzinelli, R. T., A. Talvani, M. M. Camargo, H. C. Santiago, M. A. Oliveira, L. Q. Vieira, G. A. Martins, J. C. Aliberti, and J. S. Silva. 1998. Induction of cell-mediated immunity during early stages of infection with intracellular protozoa. Braz. J. Med. Biol. Res. 31:89-104.
10. Gazzinelli, R. T., P. Oswald, S. Hienv, L. James, and A. Sher. 1992. The microbial activity of IFN-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by IL-10 TGF-β. Eur. J. Immunol. 22:2501-2506.
11. Higuchi, M. L., T. de Brito, M. M. Reis, A. Barbosa, G. Bellotti, A. C. Pereira-Barreto, and F. Pileggi. 1993. Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: light microscopy and immunohistochemical findings. Cardiovasc. Pathol. 2:101-106.
12. Higuchi, M. L., M. M. Reis, V. D. Aiello, L. A. Benvenuti, P. S. Gutierrez, G. Bellotti, and F. Pileggi. 1997. Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am. J. Trop. Med. Hyg. 56:485-589.
13. Jung, T., U. Schauer, C. Heusser, C. Neumann, and C. Rieger. 1993. Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods 159: 197-207.
14. Kemp, K., L. Hviid, A. Kharazmi, and M. Kemp. 1997. Interferon-gamma production by human T cells and natural killer cells in vitro in response to antigens from the two intracellular pathogens Mycobacterium tuberculosis and Leishmania major. Scand. J. Immunol. 46:495-499.
15. Liesenfeld, O., J. Kosek, J. S. Remington, and Y. Suzuki. 1996. Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. Med. 84:597-607.
16. Michailowsky, V., S. M. Murta, L. Carvalho-Oliveira, M. E. Pereira, L. R. Ferreira, Z. Brener, A. J. Romanha, and R. T. Gazzinelli. 1998. Interleukin 12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi. Antimicrob. Agents Chemother. 42:2549-2556.
17. + T cells. Infect. Immun. 61:3130-3738.
18. Palomino, S. A., V. D. Aiello, and M. L. Higuchi. 2000. Systematic mapping of hearts from chronic chagasic patients: the association between the occurrence of histopathological lesions and Trypanosoma cruzi antigens. Ann. Trop. Med. Parasitol. 94:571-579.
19. Prussin, C., and D. D. Metcalfe. 1995. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J. Immunol. Methods 88:117-128.
20. Purner, M. B., R. L. Berens, P. B. Nash, A. van Linden, E. Ross, C. Kruse, E. C. Krug, and T. J. Curiel. 1996. CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans. Infect. Immun. 64:4330-4338.
21. Reed, S. G. 1988. In vivo administration of recombinant IFN-γ induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infection. J. Immunol. 140: 4342-4347.
22. Reed, S. G., C. E. Brownell, D. M. Russo, J. S. Silva, K. H. Grabstein, and P. J. Morrissey. 1994. IL-10 mediates susceptibility to Trypanosoma cruzi infection. J. Immunol. 153:3135-3140.
23. Reis, D. D., E. M. Jones, S. Tostes, G. Gazzinelli, D. G. Colley, and T. McCurley. 1993. Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of TNF-alpha+ cells and dominance of Granzyme A+, CD8+ lymphocytes. Am. J. Trop. Med. Hyg. 43:637-644.
24. Reis, M. M., M. L. Higuchi, L. A. Benuenuti, V. D. Aiello, P. S. Gutierrez, G. Bellotti, and F. Pileggi. 1997. An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin. Immunol. Immunopathol. 830:165-172.
25. Ribeiro-Dos-Santos, R., J. O. Mengel, E. Postol, R. A. Soares, E. Ferreira-Fernandez, M. B. Soares, and L. C. Pontes-De-Carvalho. 2001. A heart-specific CD4+ T-cell line obtained from a chronic chagasic mouse induces carditis in heart-immunized mice and rejection of normal heart transplants in the absence of Trypanosoma cruzi. Parasite Immunol. 23:93-101.
26. Ribeiro-dos-Santos, R. R., M. A. Rossi, J. L. Laus, J. S. Silva, W. Savino, and J. Mengel. 1992. Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. J. Exp. Med. 175:29-39.
27. Sher, A., R. T. Gazzinelli, D. Jankovic, T. Schaton-Kerstein, G. Yap, T. M. Doherty, and T. Wynn. 1998. Cytokines as determinants of disease and disease interection. Braz. J. Med. Biol. Res. 31:85-87.
28. Silva, J. S., P. J. Morriessey, K. H. Grabstein, K. M. Mohler, D. Anderson, and S. G. Reed. 1992. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J. Exp. Med. 175:169-174.
29. Silva, L. H., and V. Nussensweig. 1953. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para camundongo branco. Folia Clin. Biol. 20:191-207.
30. Soares, M. B., K. N. Silva-Mota, R. S. Lima, M. C. Bellintani, L. Pontes-de-Carvalho, and R. Ribeiro-dos-Santos. 2001. Modulation of chagasic cardiomyopathy by IL-4: dissociation between inflammatory and tissue parasitism. Am. J. Pathol. 159:703-709.
31. Soares, M. B., L. Pontes-de-Carvalho, and R. Ribeiro-dos-Santos. 2001. The pathogenesis of Chagas disease: when autoimmune and parasite-specific immune responses meet. An. Acad. Bras. Cienc. 73:547-559.
32. Tarleton, R. L., and L. Zhang. 1999. Chagas disease etiology: autoimmunity or parasite persistence? Parasitol. Today 15:94-99.
33. Tsuji, M., P. Romero, R. S. Nussenzweig, and F. Zavala. 1990. CD4+ cytolytic T cell clone confers protection against murine malaria. J. Exp. Med. 172:1353-1357.
34. World Health Organization. 1997. Chagas disease, p. 112-123. In UNDP/ World bank/W. H. O. special programme for research and training in tropical disease research: progress 1995-96. Thirteenth programme report of the UNPD/World bank/W. H. O. Special Programme for Research and Training in Tropical Disease. World Health Organization, Geneva, Switzerland.
35. Yang, T. H., F. Aosai, K. Norose, M. Ueda, and A. Yano. 1995. Enhanced cytotoxicity of IFN-gamma-producing CD4+ cytotoxic T lymphocytes specific for T. gondii-infected human melanoma cells. J. Immunol. 154:290-298.
36. Zhang, L., and R. L. Tarleton. 1996. Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Eur. J. Immunol. 26:102-109.